ReviewCancers2021
Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma.
Ketao Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ReviewCancers2021
Ketao Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.